Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Vaccination of children with a live-attenuated, intranasal influenza vaccine - analysis and evaluation through a Health Technology Assessment.

Andersohn F, Bornemann R, Damm O, Frank M, Mittendorf T, Theidel U.

GMS Health Technol Assess. 2014 Oct 30;10:Doc03. doi: 10.3205/hta000119. eCollection 2014.

2.

Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany.

Damm O, Eichner M, Rose MA, Knuf M, Wutzler P, Liese JG, Krüger H, Greiner W.

Eur J Health Econ. 2015 Jun;16(5):471-88. doi: 10.1007/s10198-014-0586-4. Epub 2014 May 25.

3.

Multivariate analysis of factors affecting the immunogenicity of trivalent inactivated influenza vaccine in school-age children.

Freeman G, Ng S, Perera RA, Fang VJ, Ip DK, Leung GM, Peiris JS, Cowling BJ.

Epidemiol Infect. 2015 Feb;143(3):540-9. doi: 10.1017/S0950268814000855. Epub 2014 May 1.

4.

Cost-effectiveness of alternative strategies for annual influenza vaccination among children aged 6 months to 14 years in four provinces in China.

Zhou L, Situ S, Feng Z, Atkins CY, Fung IC, Xu Z, Huang T, Hu S, Wang X, Meltzer MI.

PLoS One. 2014 Jan 31;9(1):e87590. doi: 10.1371/journal.pone.0087590. eCollection 2014.

5.

Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011.

Kostova D, Reed C, Finelli L, Cheng PY, Gargiullo PM, Shay DK, Singleton JA, Meltzer MI, Lu PJ, Bresee JS.

PLoS One. 2013 Jun 19;8(6):e66312. doi: 10.1371/journal.pone.0066312. Print 2013.

6.

Influenza vaccines in low and middle income countries: a systematic review of economic evaluations.

Ott JJ, Klein Breteler J, Tam JS, Hutubessy RC, Jit M, de Boer MR.

Hum Vaccin Immunother. 2013 Jul;9(7):1500-11. doi: 10.4161/hv.24704. Epub 2013 May 31. Review.

7.

Economic benefits of inactivated influenza vaccines in the prevention of seasonal influenza in children.

Salleras L, Navas E, Torner N, Prat AA, Garrido P, Soldevila N, Domínguez A.

Hum Vaccin Immunother. 2013 Mar;9(3):707-11. Epub 2013 Jan 7.

8.

Relative impact of influenza and respiratory syncytial virus in young children.

Bourgeois FT, Valim C, McAdam AJ, Mandl KD.

Pediatrics. 2009 Dec;124(6):e1072-80. doi: 10.1542/peds.2008-3074. Epub 2009 Nov 23.

9.

Estimates of US influenza-associated deaths made using four different methods.

Thompson WW, Weintraub E, Dhankhar P, Cheng PY, Brammer L, Meltzer MI, Bresee JS, Shay DK.

Influenza Other Respir Viruses. 2009 Jan;3(1):37-49. doi: 10.1111/j.1750-2659.2009.00073.x.

10.

Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons.

Blank PR, Schwenkglenks M, Szucs TD.

BMC Public Health. 2008 Aug 1;8:272. doi: 10.1186/1471-2458-8-272.

11.

The cost of community-managed viral respiratory illnesses in a cohort of healthy preschool-aged children.

Lambert SB, Allen KM, Carter RC, Nolan TM.

Respir Res. 2008 Jan 24;9:11. doi: 10.1186/1465-9921-9-11.

12.

Health benefits, risks, and cost-effectiveness of influenza vaccination of children.

Prosser LA, Bridges CB, Uyeki TM, Hinrichsen VL, Meltzer MI, Molinari NA, Schwartz B, Thompson WW, Fukuda K, Lieu TA.

Emerg Infect Dis. 2006 Oct;12(10):1548-58.

Supplemental Content

Support Center